These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7532462

  • 1. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.
    Ochs HD, Hollenbaugh D, Aruffo A.
    Semin Immunol; 1994 Oct; 6(5):337-41. PubMed ID: 7532462
    [Abstract] [Full Text] [Related]

  • 2. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
    Saiki O, Tanaka T, Wada Y, Uda H, Inoue A, Katada Y, Izeki M, Iwata M, Nunoi H, Matsuda I.
    J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
    [Abstract] [Full Text] [Related]

  • 3. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
    Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE.
    Semin Immunol; 1994 Oct; 6(5):295-301. PubMed ID: 7532459
    [Abstract] [Full Text] [Related]

  • 4. The expansive role of CD40 and its ligand, gp39, in immunity.
    Foy TM, Durie FH, Noelle RJ.
    Semin Immunol; 1994 Oct; 6(5):259-66. PubMed ID: 7532456
    [Abstract] [Full Text] [Related]

  • 5. In vivo T-B cell interactions and cytokine-production in the spleen.
    van den Eertwegh AJ, Laman JD, Noelle RJ, Boersma WJ, Claassen E.
    Semin Immunol; 1994 Oct; 6(5):327-36. PubMed ID: 7532461
    [Abstract] [Full Text] [Related]

  • 6. CD40 and its ligand in the regulation of humoral immunity.
    Klaus SJ, Berberich I, Shu G, Clark EA.
    Semin Immunol; 1994 Oct; 6(5):279-86. PubMed ID: 7532458
    [Abstract] [Full Text] [Related]

  • 7. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.
    Nishioka Y, Lipsky PE.
    J Immunol; 1994 Aug 01; 153(3):1027-36. PubMed ID: 7517971
    [Abstract] [Full Text] [Related]

  • 8. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
    Korthäuer U, Graf D, Mages HW, Brière F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA.
    Nature; 1993 Feb 11; 361(6412):539-41. PubMed ID: 7679206
    [Abstract] [Full Text] [Related]

  • 9. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.
    Ochs HD, Hollenbaugh D, Aruffo A.
    Res Immunol; 1994 Feb 11; 145(3):210-5; discussion 244-9. PubMed ID: 7527577
    [No Abstract] [Full Text] [Related]

  • 10. B cells from CBA/N mice do not proliferate following ligation of CD40.
    Hasbold J, Klaus GG.
    Eur J Immunol; 1994 Jan 11; 24(1):152-7. PubMed ID: 7517360
    [Abstract] [Full Text] [Related]

  • 11. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
    Durandy A, Schiff C, Bonnefoy JY, Forveille M, Rousset F, Mazzei G, Milili M, Fischer A.
    Eur J Immunol; 1993 Sep 11; 23(9):2294-9. PubMed ID: 7690328
    [Abstract] [Full Text] [Related]

  • 12. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
    Grabstein KH, Maliszewski CR, Shanebeck K, Sato TA, Spriggs MK, Fanslow WC, Armitage RJ.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3141-7. PubMed ID: 7682232
    [Abstract] [Full Text] [Related]

  • 13. CD40 ligand and its role in X-linked hyper-IgM syndrome.
    Callard RE, Armitage RJ, Fanslow WC, Spriggs MK.
    Immunol Today; 1993 Nov 15; 14(11):559-64. PubMed ID: 7506037
    [Abstract] [Full Text] [Related]

  • 14. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
    Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M.
    Cell; 1993 Jan 29; 72(2):291-300. PubMed ID: 7678782
    [Abstract] [Full Text] [Related]

  • 15. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
    Durandy A, De Saint Basile G, Lisowska-Grospierre B, Gauchat JF, Forveille M, Kroczek RA, Bonnefoy JY, Fischer A.
    J Immunol; 1995 Feb 15; 154(4):1560-8. PubMed ID: 7530739
    [Abstract] [Full Text] [Related]

  • 16. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.
    Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, Noelle RJ, Aruffo A, Ochs HD.
    Proc Natl Acad Sci U S A; 1994 Feb 01; 91(3):1099-103. PubMed ID: 7508119
    [Abstract] [Full Text] [Related]

  • 17. Structural characteristics of CD40 ligand that determine biological function.
    Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ.
    Semin Immunol; 1994 Oct 01; 6(5):267-78. PubMed ID: 7532457
    [Abstract] [Full Text] [Related]

  • 18. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function.
    Yellin MJ, Sippel K, Inghirami G, Covey LR, Lee JJ, Sinning J, Clark EA, Chess L, Lederman S.
    J Immunol; 1994 Jan 15; 152(2):598-608. PubMed ID: 7506727
    [Abstract] [Full Text] [Related]

  • 19. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.
    Bajorath J, Seyama K, Nonoyama S, Ochs HD, Aruffo A.
    Protein Sci; 1996 Mar 15; 5(3):531-4. PubMed ID: 16509032
    [Abstract] [Full Text] [Related]

  • 20. Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens.
    Gordon J, Katira A, Holder M, MacDonald I, Pound J.
    Cell Mol Biol (Noisy-le-grand); 1994 Mar 15; 40 Suppl 1():1-13. PubMed ID: 7524882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.